|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B
–/– Mice1From the Departments of Ophthalmology and 2Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan; the 3Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan; and the 4Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
PURPOSE. I
B
–/– mice have been reported to be affected by allergic dermatitis. This study was conducted to analyze the pathophysiological role of I
B
and to address the functional relevance of Th2-mediated immune responses in the development of ocular surface inflammation and dermatitis by I
B
–/– mice.
METHODS. BALB/c background I
B
–/– mice were established without individual differences; I
B
/Stat6 double-knockout (WKO) mice unable to produce Th2 cytokine were created; and microscopic-, histologic-, and immunochemical studies were performed. In I
B
–/– mice the serum IgE levels were examined by ELISA, and quantitative PCR was used to study the gene expression of IFN-
, IL4, IL10, TNF
, IL6, IL17
, and CCL11 in eyelid tissue.
RESULTS. I
B
–/– mice exhibited a severe inflammatory phenotype on the ocular surface and perioral skin. The inflammatory infiltrates in the perioral skin consisted primarily of CD4+ and CD8+ cells; CD4+ and CD45R/B220+ cells were mainly detected in the conjunctiva. In eyelid and perioral skin tissue, the expression of IL-17
and of Th1 and Th2 cytokines, but not of CCL11, was augmented. I
B
–/– and I
B
+/– mice did not differ significantly in their serum total IgE levels before, 0 to 4 weeks, and 5 to 9 weeks after disease onset. I
B
/Stat6 WKO mice showed the same or slightly more severe inflammation than did I
B
–/– mice.
CONCLUSIONS. IgE and Stat6 are not responsible for the immune pathologic response leading to the development of ocular surface and perioral skin inflammation in I
B
–/– mice. I
B
–/– mice may be a suitable model for Stevens-Johnson syndrome, but not for atopic dermatitis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |